These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2653696)
1. Pharmacokinetic disposition of quinolones in human body fluids and tissues. Sörgel F; Jaehde U; Naber K; Stephan U Clin Pharmacokinet; 1989; 16 Suppl 1():5-24. PubMed ID: 2653696 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and tissue penetration of the fluoroquinolones. Bergeron MG Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review. Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896 [TBL] [Abstract][Full Text] [Related]
5. Penetration of temafloxacin into body tissues and fluids. Sörgel F Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872 [TBL] [Abstract][Full Text] [Related]
8. Tissue penetration of the new quinolones in humans. Gerding DN; Hitt JA Rev Infect Dis; 1989; 11 Suppl 5():S1046-57. PubMed ID: 2672243 [TBL] [Abstract][Full Text] [Related]
9. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves. Friis C Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371 [TBL] [Abstract][Full Text] [Related]
11. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)]. Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259 [TBL] [Abstract][Full Text] [Related]
12. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [TBL] [Abstract][Full Text] [Related]
13. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions. Sörgel F; Kinzig M Am J Med; 1993 Mar; 94(3A):56S-69S. PubMed ID: 8383921 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the newer fluoroquinolones. Brouwers JR Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S16-22. PubMed ID: 3325926 [TBL] [Abstract][Full Text] [Related]
18. Clinical role of protein binding of quinolones. Bergogne-Bérézin E Clin Pharmacokinet; 2002; 41(10):741-50. PubMed ID: 12162760 [TBL] [Abstract][Full Text] [Related]
19. Distribution of ciprofloxacin in the dog prostate and various tissues. Frimodt-Møller PC; Dørflinger T; Madsen PO Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821 [TBL] [Abstract][Full Text] [Related]
20. Drug interactions with quinolones. Lode H Rev Infect Dis; 1988; 10 Suppl 1():S132-6. PubMed ID: 3279488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]